Evidence mapPaperPMID 39619157Full record

ArticleOpen research Europe2023

Fabrication of hydrogel mini-capsules as carrier systems.

Elisa Roberti, Gaia Petrucci, Francesco Bianciardi, Stefano Palagi

Abstract read
In one paragraph

Article in Open research Europe, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elisa Roberti *The BioRobotics Institute, Sant'Anna School of Advanced Studies, Pisa, Tuscany, 56025, Italy.ORCID https://orcid.org/0000-0001-8938-0289
Gaia Petrucci *The BioRobotics Institute, Sant'Anna School of Advanced Studies, Pisa, Tuscany, 56025, Italy.
Francesco BianciardiThe BioRobotics Institute, Sant'Anna School of Advanced Studies, Pisa, Tuscany, 56025, Italy.ORCID https://orcid.org/0000-0001-8944-2769
Stefano PalagiThe BioRobotics Institute, Sant'Anna School of Advanced Studies, Pisa, Tuscany, 56025, Italy.ORCID https://orcid.org/0000-0001-7284-0007

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conventional drug administration often results in systemic action, thus needing high dosages and leading to potentially pronounced side effects. Targeted delivery, employing carriers like nanoparticles, aims to release drugs at a target site, but only a small fraction of nanoparticles reaches it. Microrobots could overcome this issue, being guided to hard-to-reach sites and locally delivering payloads. To enhance their functionality, we propose microrobots made as deformable capsules with hydrogel shells and aqueous cores, having the potential added advantages of biocompatibility, permeability, and stimulus-responsiveness. Endowing microrobots with deformability could allow them to navigate inside capillaries and cross barriers to finally reach the target site. In this study, we present a cost-effective method for fabricating core-shell structures without the use of organic solvents, surfactants, or extreme pH conditions. First, a mixture of hydrogels, agarose and alginate, is dripped into a calcium chloride solution to form beads. After they are loaded with calcium ions at different concentrations, they are immersed in an alginate solution to form the shell. Finally, the beads are heated to let the agarose melt and diffuse out, leaving a liquid core. By varying the concentration of calcium ions, we obtain shells of different thicknesses. We have correlated the measured shell thickness to its colour intensity and extrapolated to estimate the thickness of shells too thin to be measured directly. This allowed us to conclude that no continuous shells forms below a certain calcium chloride concentration. For higher concentrations, although the core may remain partially gelled, continuous shells successfully form. To qualitative assess core-shell capsule deformability, we forced them through a tube with an inner diameter ~1.6 times smaller than the average capsule diameter. The capsules deformed to pass through the constriction while maintaining structural integrity. Therefore, our fabrication method offers a promising platform for applications in drug delivery, encapsulation systems, and microrobotics.

Indexed as

agarosealginatecore-shellhydrogel capsulesmicrorobotics

Identifiers

PMID39619157
PMCPMC11605173

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.